"Designing Growth Strategies is in our DNA"
Short Tandem Repeats (STR) are the DNA regions with short repeat elements (usually 2-6 bp in length). Short tandem repeats are originated from the surroundings of chromosomal centromere (structural center of the chromosomes). Short tandem repeats have been demonstrated to have several benefits that make them completely suitable for human identification. Short Tandem Repeats analysis involves the extraction of nuclear DNA from cells in a sample, and certain regions of the DNA are later amplified with the help of the polymerase chain reaction technology.
Rise in the number of criminal cases combined with the increased rate of accidents leading to loss of memory, is subsequently leading to the increasing demand for the short tandem repeats testing for the detection of the identity of an individual. Also, increased investment in the research and development for genetic diseases and increasing investment healthcare and biotechnology companies are some of the major factors expected to drive the growth of the global short tandem repeats (STR) testing market during the forecast period
The factors that are expected to inhibit the growth of the global short tandem repeats (STR) testing market are the production of artifacts during the amplification process, inability of the technique to distinguish between male relatives and the limitations of the haplotype frequency approach.
To gain extensive insights into the market, Request for Customization
Some of the major companies that are present in the global Short Tandem Repeats Testing market are Thermo Fisher Scientific, Promega Corporation., AB Sciex, Independent Forensics., General Electric, DNA Labs International, Inc., DNA Forensics Laboratory Pvt. Ltd., Hy Laboratories Ltd., Illumina, Inc., EasyDNA, Devyser, and others.
SEGMENTATION | DETAILS |
By Kits | · Y- short tandem repeats test kits · Short tandem repeats test kit · Mini- short tandem repeats test kit |
By End User | · Forensic laboratories · Research institutes · Others. |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
In 2018, cancer accounted for the largest share of the global short tandem repeats testing market, and is projected to continue dominance during the forecast period. Based on research study conducted by the Massachusetts Institute of Technology (MIT), out of projected 40 FDA-approved short tandem repeats testing products by 2022, around half are expected to be in the oncology space.
Among the region, North America accounted for the largest share of the global short tandem repeats testing market in 2018. Increasing investment in the research and development and high demand for genetic counseling are factors driving the growth of the short tandem repeats testing market in the North America region. In the U.S., the 13-STR profile is a widely used means of identification, and this technology is now regularly employed to identify human remains, to establish or exclude paternity, or to match a suspect to a crime scene sample. Asia Pacific is expected to register a comparatively higher CAGR, due to the rising adoption of genetic testing methods, increasing R&D focus by market players, and increasing government funding for research activities.
US +1 833 909 2966 ( Toll Free )